Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See More
Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See MoreDear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Analysis of Erk1/2 (pT202/pY204) in human peripheral blood lymphocytes. Whole blood was either left untreated (unshaded) or treated (shaded) with 400nM of phorbol 12-myristate 13-acetate (PMA) (Sigma, Cat.# P8139) for 15 minutes at 37°C. The samples were lysed and fixed with 1X BD Phosflow™ Lyse/Fix buffer (Cat. No. 558049) for 10 minutes at 37°C, permeabilized (BD Phosflow™ Perm Buffer III, Cat. No. 558050) on ice for 30 minutes and were then stained with PE-CY™7 anti-Erk1/2 (pT202/pY204). For data analysis, lymphocytes were selected by scatter profile. Flow cytometry was performed on a BD FACSCalibur™ II flow cytometry system.
Analysis of Erk1/2 (pT202/pY204) in human peripheral blood lymphocytes. Whole blood was either left untreated (unshaded) or treated (shaded) with 400nM of phorbol 12-myristate 13-acetate (PMA) (Sigma, Cat.# P8139) for 15 minutes at 37°C. The samples were lysed and fixed with 1X BD Phosflow™ Lyse/Fix buffer (Cat. No. 558049) for 10 minutes at 37°C, permeabilized (BD Phosflow™ Perm Buffer III, Cat. No. 558050) on ice for 30 minutes and were then stained with PE-CY™7 anti-Erk1/2 (pT202/pY204). For data analysis, lymphocytes were selected by scatter profile. Flow cytometry was performed on a BD FACSCalibur™ II flow cytometry system.
Analysis of Erk1/2 (pT202/pY204) in human peripheral blood lymphocytes. Whole blood was either left untreated (unshaded) or treated (shaded) with 400nM of phorbol 12-myristate 13-acetate (PMA) (Sigma, Cat.# P8139) for 15 minutes at 37°C. The samples were lysed and fixed with 1X BD Phosflow™ Lyse/Fix buffer (Cat. No. 558049) for 10 minutes at 37°C, permeabilized (BD Phosflow™ Perm Buffer III, Cat. No. 558050) on ice for 30 minutes and were then stained with PE-CY™7 anti-Erk1/2 (pT202/pY204). For data analysis, lymphocytes were selected by scatter profile. Flow cytometry was performed on a BD FACSCalibur™ II flow cytometry system.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
This antibody conjugate is suitable for intracellular staining of human whole blood (using BD Phosflow™ Lyse/Fix Buffer) and peripheral blood mononuclear cells (using BD Cytofix™ Fixation Buffer or BD Phosflow™ Fix Buffer I). Any of the three BD Phosflow™ permeabilization buffers may be used.
This mAb was characterized by flow cytometry (Flow) and western blot analysis (WB) using these model systems:
Method Species Cells Treatment Fixation Perm buffer Result
Flow Human PBMC PMA Fixation Buffer I, II or III Positive Staining
Flow Human Whole Blood PMA Lyse/Fix I, II or III Positive Staining
WB Human A431 Cell Lysate EGF Not Applicable Not Applicable 44/42 kDa
The members of the Mitogen-Activated Protein Kinase (MAPK) family are components of a key signal transduction cascade that links events at the cell surface to responses in the nucleus. The signaling cascade is found in species as varied as yeast and humans, with many of the proteins being well conserved. In mammals the most widely studied members of the cascade are the Extracellular signal-Regulated Kinases, ERK1 (p44 MAPK) and ERK2 (p42 MAPK). ERK1 and ERK2 share 85% homology and are activated by extracellular signals such as growth factors, hormones, and phorbol esters. Activation occurs through a series of phosphorylations by kinases activating other kinases and eventually leading to phosphorylation of the ERKs. Growth factor stimulation leads to activation of Ras and Raf, leading to phosphorylation of MEK1 (MAPK/ERK kinase) which, in turn, activates the ERKs via dual phosphorylation. Once activated, the ERKs phosphorylate other cytoplasmic signalling molecules, cell-surface receptors, microtubule-associated proteins, and transcription factors in the nucleus. Thus, the active ERK has myriad downstream effectors that implicate it in the control of cell proliferation and differentiation, as well as regulation of the cytoskeleton. Furthermore, studies have shown that elevated ERK activity is associated with some cancers.
The 20A monoclonal antibody recognizes the phosphorylated threonine 202 and tyrosine 204 (pT202/pY204) of human ERK1 and pT184/pY186 of human ERK2. The orthologous phosphorylation sites in murine ERK1 and ERK2 are T203/Y205 and T183/Y185.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.